EUVIMEDEUVIMED entdecken
Crossref

Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity

Mansi Arora, Justin Moser, Timothy E Hoffman, Lotte P Watts, Mingwei Min, Monica Musteanu, Yao Rong, C Ryland Ill, Varuna Nangia, Jordan Schneider, Manuel Sanclemente, John Lapek und 7 weitere

Cell · 2023-06 · 186 (12) · 2628-2643.e21

DOI: 10.1016/j.cell.2023.05.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2023-06. Verfasst von Mansi Arora und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinases, Cell Cycle Proteins. Die Arbeit wurde bisher 169-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: NIH HHS, Pfizer Inc, University of Colorado Boulder.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent KinasesCell Cycle ProteinsAnimalsMiceCell CycleCyclin-Dependent Kinase 2PhosphorylationCell Division

Stichwörter der Autor:innen

CDK plasticityCDK2CDK4/6PF-06873600PF-07104091PalbociclibRbcyclin Adrug adaptationrestriction point

Substanzen

Cyclin-Dependent KinasesCyclin-Dependent Kinase 2Cell Cycle Proteins

Autor:innen und Institutionen

  • Department of Biochemistry and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA.
  • Department of Biochemistry and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA; Guangzhou Laboratory, Guangzhou, Guangdong, China.
  • Experimental Oncology Group, Molecular Oncology Programme, Spanish National Cancer Research Centre, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madr…
  • Department of Biochemistry and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA; Department of Molecular, Cellular, and Developmental Biology and BioFrontiers Institute, University of Color…
  • Experimental Oncology Group, Molecular Oncology Programme, Spanish National Cancer Research Centre, Madrid, Spain.
  • Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA 92121, USA.

Förderung

  • NIH HHS
  • Pfizer Inc
  • University of Colorado Boulder
  • National Institutes of Health

Zitieren

APA

Arora, M., Moser, J., Hoffman, T. E., Watts, L. P., Min, M., Musteanu, M., Rong, Y., Ill, C. R., Nangia, V., Schneider, J., Sanclemente, M., Lapek, J., Nguyen, L., Niessen, S., Dann, S., VanArsdale, T., Barbacid, M., Miller, N., & Spencer, S. L. (2023). Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity. Cell, 186(12), 2628-2643.e21. https://doi.org/10.1016/j.cell.2023.05.013

Vancouver

Arora M, Moser J, Hoffman TE, Watts LP, Min M, Musteanu M, et al. Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity. Cell. 2023;186(12):2628-2643.e21. doi:10.1016/j.cell.2023.05.013

BibTeX
@article{Arora2023,
  author = {Arora, Mansi and Moser, Justin and Hoffman, Timothy E and Watts, Lotte P and Min, Mingwei and Musteanu, Monica and Rong, Yao and Ill, C Ryland and Nangia, Varuna and Schneider, Jordan and Sanclemente, Manuel and Lapek, John and Nguyen, Lisa and Niessen, Sherry and Dann, Stephen and VanArsdale, Todd and Barbacid, Mariano and Miller, Nichol and Spencer, Sabrina L},
  title = {Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity},
  journal = {Cell},
  year = {2023},
  volume = {186},
  number = {12},
  pages = {2628--2643.e21},
  doi = {10.1016/j.cell.2023.05.013}
}
Kostenlos starten →